Home - Kumar Group

Welcome to Our Group

We are delighted to have you explore our research. Our group is dedicated to advancing the frontiers of organic chemistry, medicinal chemistry, and drug discovery.

Our research centres on the discovery and development of novel bioactive molecules for industrial and medical applications. Naturally produced chemicals play fundamental roles in biological systems, yet many are available only in trace amounts. Through innovative organic synthesis, we access these molecules and their analogues, enabling full assessment of biological activity, mode of action, and the development of new therapeutic leads. Our work is multi-disciplinary, combining synthetic organic chemistry, molecular modelling, and biological screening.

Our Research

Discover our research areas in Organic chemistry and drug discovery

Explore All Research

Organic/Medicinal Chemistry

Our group focuses on the design and synthesis of novel drug candidates for various therapeutic targets, with a particular emphasis on cancer and infectious diseases.

Drug Discovery

We employ state-of-the-art techniques in Organic/Medicinal Chemistry, including structure-based drug design, fragment-based drug discovery, and high-throughput screening.

Chemical Biology

Our research integrates chemical synthesis with biological studies to understand disease mechanisms and develop new therapeutic strategies.

Computational Drug Discovery

We use AI, machine learning, deep learning, molecular docking, and simulation to accelerate drug discovery and design.

Latest News

Professor Naresh Delivers Engaging Talk at Asia-Pacific Biofilms 2026

March 31, 2026

Professor Naresh Kumar presented new quinazolinone-based PqsR antagonists at Asia-Pacific Biofilms 2026, highlighting promising anti-virulence strategies against Pseudomonas aeruginosa.

Professor Naresh Delivers Engaging Talk at Asia-Pacific Biofilms 2026

March 31, 2026

Professor Naresh Kumar presented new quinazolinone-based PqsR antagonists at Asia-Pacific Biofilms 2026, highlighting promising anti-virulence strategies against Pseudomonas aeruginosa.

Tope A. Ibisanmi Delivered a Talk at Asia-Pacific Biofilms 2026

March 29, 2026

At Asia-Pacific Biofilms 2026 in Melbourne, Tope A. Ibisanmi presented multidisciplinary peptidomimetic research targeting multidrug-resistant bacteria and biofilm-associated infections.

Congratulations to Valerio and Josh on their Graduation

March 23, 2026

Congratulations to Dr. Valerio Falasca on completing his PhD, and to Josh Fleming on completing Honours. We are proud of your achievements with the Kumar Group and wish you both...

View All News